Skip to main content
Clinical Trials/NCT02417623
NCT02417623
Unknown
Not Applicable

Efficacy of a Mobile Application for Weight Loss in Overweight and Obese Adults: A Randomized Controlled Trial

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina1 site in 1 country76 target enrollmentJanuary 2015
ConditionsObesity

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Enrollment
76
Locations
1
Primary Endpoint
Body mass index (Kg/m2)
Last Updated
11 years ago

Overview

Brief Summary

AIM: To assess the efficacy of an intervention that includes the assistance of a weight loss smartphone application targeted to young people aged 18 to 40 years.

DESIGN: Randomisedclinical trial.

SETTING: Primary Health Care centres (PHCCs) in Catalonia.

PARTICIPANTS: Adults aged 18 to 40 years with criteria of obesity or overweight, consulting PHCCs for any reason and who provide written informed consent to participate in the trial.

INTERVENTION GROUP will receive a 12-month weight loss programme that implements recommendations of a Clinical Practice Guideline, complemented with a smartphone app designed specifically for this programme.

CONTROL GROUP will receive the usual care. The outcome measure will be weight loss at 12 months.

EXPECTED RESULTS: The investigators expect a higher weight loss in the intervention group than in control group.

Detailed Description

DESIGN: Randomised clinical trial. SETTING: Primary Health Care centres (PHCCs) in Catalonia, Spain. PARTICIPANTS: Adults aged 18 to 40 years with criteria of obesity or overweight, consulting PHCCs for any reason and who provide written informed consent to participate in the trial. INTERVENTION GROUP will receive a 12-month weight loss programme that implements recommendations of a Clinical Practice Guideline, complemented with a smartphone app designed specifically for this programme. CONTROL GROUP will receive the usual care. The outcome measure will be weight loss at 12 months. EXPECTED RESULTS: The investigators expect a higher weight loss in the intervention group than in control group.

Registry
clinicaltrials.gov
Start Date
January 2015
End Date
January 2017
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Young adults aged 18 to 40 years with overweight or obesity
  • availability of the patient's clinical history in the primary care centre
  • access to a smartphone device that meets the app requirements
  • access to an Internet data connection

Exclusion Criteria

  • Morbid obesity with BMI\> 40
  • Secondary Obesity (eg endocrine pathology)
  • eating disorders (the patient or any member of the family);
  • Presence of any significant comorbidity that a specific treatment (type 1 diabetes mellitus, severe mental illness);
  • pregnant or desire pregnancy in the next 12 months;
  • To participate in a weight loss program or taking any medication for weight loss in the moment of the recruitment
  • Take any medication that may influence body weight;

Outcomes

Primary Outcomes

Body mass index (Kg/m2)

Time Frame: 12 months

change in body mass index at 12 months in the experimental group, compared with the control group.. At each study visit, anthropometrics will be recorded by a primary care nurse or doctor. Body weight will be measured with the participant dressed in light clothing with shoes off on a calibrated balance.

Body weight (Kg)

Time Frame: 12 months

Change in body weight at 12 months in the experimental group, compared with the control group. At each study visit, anthropometrics will be recorded by a primary care nurse or doctor. Body weight will be measured with the participant dressed in light clothing with shoes off on a calibrated balance.

Secondary Outcomes

  • Physical activity measured with two brief validated questionnaires(12 months)
  • glucemic levels(12 months)
  • GPT levels(12 months)
  • cholesterol profile (LDL-cholesterol, HDL-Cholesterol, Cholesterol total)(12 months)
  • blood pressure(12 months)

Study Sites (1)

Loading locations...

Similar Trials